GL1X · GenesisL1 explorer

Research workbench

Crystal structure of MGLUR5 in complex with fenobam at 2.65 a

Analyse Crystal structure of MGLUR5 in complex with fenobam at 2.65 a in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6FFH
Type
protein
Length
414 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Metabotropic glutamate receptor 5,ENDOLYSIN
EC
3.2.1.17
UniProt
P41594, P00720
Ligands
OLA, D7W
Pockets
2 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 72% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMetabotropic glutamate receptor 5,ENDOLYSIN (EC 3.2.1.17)protein41472% helix, 5% strandP41594, P00720

Ligands and binding sites

  • OLA · Oleic acid · ligand · 5 copies · chains A
  • D7W · 1-(3-chlorophenyl)-3-(3-methyl-5-oxidanylidene-4~{H}-imidazol-2-yl)urea · ligand · chains A
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · chains A
  • OLC · (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12520.780.9042D7W
25040.680.7949empty

Modifications

Observed in the structure: 1 disulfide, 1 modified (disulfide, alkylation).

Compared structures

  • 6FFH · Crystal Structure of mGluR5 in complex with Fenobam at 2.65 A · the same entry in another collection · chain A against A, TM-score 1.00
  • P41594 · AlphaFold monomer V2.0 prediction for metabotropic glutamate receptor 5 (P41594) · a predicted model of the same protein · chain A against A, TM-score 0.58

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.